Hematopoietic SCT for peripheral T-cell lymphoma Gutiérrez A, Caballero D, Pérez-Manga G, Rodriguez J. Bone Marrow Transplantation 42(12):773-81. FI: 2.998 (Q3) The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia Delgado J, Pillai S, Benjamin R, Caballero D, Martino R, Nathwani A, Lovell R, Thomson K, Perez-Simon JA, Sureda A, Kottaridis P, Vazquez L, Peggs K, Sierra J, Milligan D, Mackinnon S. Biology of Blood and Marrow 14(11):1288-97. FI: 3.149 (Q2) Cloozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients Molina V, Tamayo P, Montes C, De Luxán A, Martín C, Rivas N, Sancho C, Domínguez-Gil A. Progress in Neuropsychopharmacology and Biological Psychiatry 32(4):948-54. FI: 2.823 (Q2) Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin¿s lymphoma in Spain Sancho JM, Morgades M, Alonso N, Deben G, Fernández de Sevilla A, Vázquez L, Nicolás C, García Vela JA, Arranz R, Abella E, Canales MA, Miralles P, Sánchez E, Hermosilla M, Conde E, Rueda A, Ribera JM, investigators of QUIT Study (PETHEMA, GELTAMO and GOTEL Groups). Medicina Clínica 131(12):441-6. FI: 1.231 (Q3) Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin¿s lymphoma in Spain Sancho JM, Morgades M, Alonso N, Deben G, Fernández de Sevilla A, Vázquez L, Nicolás C, García Vela JA, Arranz R, Abella E, Canales MA, Miralles P, Sánchez E, Hermosilla M, Conde E, Rueda A, Ribera JM, investigators of QUIT Study(PETHEMA, GELTAMO and GOTEL Groups). Medicina Clínica 131(12):441-6. FI: 1.231 (Q3) The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes Tabera S, Pérez-Simón JA, Díez-Campelo M, Sánchez-Abarca LI, Blanco B, López A, Benito A, Ocio E, Sánchez-Guijo FM, Cañizo C, San Miguel JF. Haematologica 93(9):1301-9. FI: 6.416 (Q1) Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting Alcoceba M, Balanzategui A, Díez-Campelo M, Martín-Jiménez P, Sarasquete ME, Chillón MC, Santamaría C, Pérez-Simón JA, Marín L, Caballero D, San Miguel JF, García-Sanz R, González M. Transplantation 86(7):983-90. FI: 3.498 (Q2) Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group Arranz R, Conde E, Grande C, Mateos MV, Gandarillas M, Albo C, Lahuerta JJ, Fernández-Rañada JM, Hernández MT, Alonso N, García Vela JA, Garzón S, Rodríguez J, Caballero D, Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea(GEL-TAMO). European Journal of Haematology 80(3):227-35. FI: 2.345 (Q3) Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis Pérez-Simón JA, Martino R, Caballero D, Valcarcel D, Rebollo N, de la Cámara R, de Oteiza JP, Heras I, Calvo MV, Sierra J, San Miguel JF, Grupo Español de Trasplante Hematopoyético(GETH). Biology of Blood and Marrow 14(6):664-71. FI: 3.149 (Q2) Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the National Institutes of Health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy Pérez-Simón JA, Encinas C, Silva F, Arcos MJ, Díez-Campelo M, Sánchez-Guijo FM, Colado E, Martín J, Vázquez L, del Cañizo C, Caballero D, San Miguel JF. Biology of Blood and Marrow 14(10):1163-71. FI: 3.149 (Q2)
|
